ClinicalTrials.gg
CompletedNCT06565312Updated Aug 21, 2024

A Single Group Study to Evaluate the Effects of a Probiotic Vaginal Suppository on Vaginal Health.

An interventional study of Flora Power Probiotic Vaginal Suppository in Vaginal Health and Vaginal pH, sponsored by Love Wellness. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-21.

Sponsored by Love Wellness · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

This is a virtual single-group clinical trial lasting 8 weeks to evaluate the effects of a probiotic vaginal suppository on vaginal health. Participants will use the Flora Power suppository daily for 5 consecutive days when experiencing common signs of vaginal imbalance. They will complete questionnaires and vaginal pH tests before and after product use.

02

Conditions studied

  • Vaginal Health
  • Vaginal pH

Keywords

  • Vaginal suppository
  • Women's Health
03

In context

Lead sponsor

Love Wellness is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female at birth, aged 18+.
  • Interested in maintaining a healthy vaginal environment.
  • Experience common signs of vaginal imbalance (e.g., malodor, irritation).
  • Willing to avoid other vaginal products and follow study protocol.

Exclusion criteria

Exclusion Criteria:

  • Recent surgeries or invasive treatments.
  • Use of vaginal health products in the last 12 weeks.
  • Allergies to product ingredients.
  • Chronic health conditions impacting participation.
  • Pregnant, breastfeeding, or trying to conceive.
  • History of substance abuse or smoking.
  • Currently participating in another clinical trial.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Flora Power Probiotic Vaginal Suppository

    Participants will use the Flora Power suppository once daily at bedtime for 5 consecutive days when they feel they are experiencing any of the common signs of vaginal imbalance like vaginal malodor, vaginal irritation, and/or vaginal itching.

    Dietary Supplement: Flora Power Probiotic Vaginal Suppository

Interventions

  • Dietary supplementFlora Power Probiotic Vaginal Suppository

    The suppository contains Microcrystalline Cellulose, Ascorbic Acid, Vitamin C, Gelatin Capsule, Vaginal Probiotic Blend (Lactobacillus fermentum LF61, Lactobacillus acidophilus LA85, Lactobacillus plantarum Lp90), Magnesium Stearate, and Silicon Dioxide.

06

What researchers measure

Primary outcomes

  1. Effect on Vaginal pH and Health

    Measure the change in vaginal pH levels with a test strip from baseline to 24 hours after the 5-day intervention period.

    Time frame: Baseline, Day 6 (24 hours after the last suppository insertion)

  2. Effect on Vaginal pH and Health

    Measure the change in overall vaginal health from baseline to 24 hours after the 5-day intervention period with a questionnaire.

    Time frame: Baseline, Day 6 (24 hours after the last suppository insertion)

Secondary outcomes

  1. Participant Perception of Vaginal Freshness and Odor

    Evaluate participants' perceptions of the vaginal suppository's impact on vaginal freshness and odor, as well as the support of a calm, soothed, and balanced vaginal environment. This outcome measure is assessed with questionnaires.

    Time frame: Baseline, Day 2, Day 5

07

Study locations

1 site
  • Citruslabs
    Santa Monica, California 90404, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2024 to primary completion in Jul 2024, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 11, 2024
First posted
Aug 21, 2024
StartActual
May 10, 2024
Primary completionActual
Jul 10, 2024
CompletionActual
Jul 10, 2024
Last update
Aug 21, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06565312
Lead sponsor
Love Wellness
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Aug 21, 2024
Start date
May 10, 2024
Primary completion
Jul 10, 2024
Completion
Jul 10, 2024
Last update
Aug 21, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion